Vernal Biosciences
Latest round
- Series A
Last raised
- Jun 2023
Total raised
- $41M
Investors
- 6
About Vernal Biosciences
Founded in 2020 and based in Vermont, US, Vernal Biosciences, Inc. operates as a manufacturer of mRNA and LNP-mRNA, platform process development technologies on a transactional basis. In June 2023, Vernal Biosciences, Inc. Vernal Biosciences' services and products include mRNA sequence design, custom mRNA, GMP mRNA manufacturing, LPN formulated mRNA, and catalog mRNA products such as reporter gene mRNA, genome editing mRNA, gene replacement mRNA, and antigen mRNA.
Who invested in Vernal Biosciences
6 investors across 2 rounds
See all investors in Vernal Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vernal Biosciences
Who invested in Vernal Biosciences?
Vernal Biosciences has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vernal Biosciences raised?
Vernal Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Vernal Biosciences last raise money?
Vernal Biosciences's most recent round on record is a Series A, in Jun 2023.
What does Vernal Biosciences do?
Founded in 2020 and based in Vermont, US, Vernal Biosciences, Inc.
Where is Vernal Biosciences headquartered?
Vernal Biosciences is headquartered in Burlington, US.
Which VCs invest in companies like Vernal Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vernal Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Vernal Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.